Tricuspid atresia overview: Difference between revisions

Jump to navigation Jump to search
Line 4: Line 4:


==Overview==
==Overview==
[[Tricuspid atresia]] is the third most common [[cyanotic]]  [[congenital heart disease]] whether the [[nonoxygenated blood]] can not flow from [[right atrium ]]to [[right ventricle]] due to nondevelopment or agenesia of the [[tricuspid valve]]. The [[right ventricle]] is small and the [[pulmonary artery]] in some cases is hypoplastic. [[ Atrial septal defect]] (ASD) or [[patent foramen oval]]([[PFO]]) is necessary for passing the [[ blood]] from the [[right atrium]] to the left system and without them, the [[infants]] will not survive. The majority of [[infants]] die without [[palliative surgery]].
[[Tricuspid atresia]] is the third most common [[cyanotic]]  [[congenital heart disease]] whether the [[nonoxygenated blood]] can not flow from [[right atrium ]]to [[right ventricle]] due to nondevelopment or agenesia of the [[tricuspid valve]]. The [[right ventricle]] is small and the [[pulmonary artery]] in some cases is hypoplastic. [[ Atrial septal defect]] (ASD) or [[patent foramen oval]] ([[PFO]]) is necessary for passing the [[ blood]] from the [[right atrium]] to the left system and without them, the [[infants]] will not survive. The majority of [[infants]] die without [[palliative surgery]].


<br />
<br />

Revision as of 13:34, 25 August 2020

Tricuspid atresia Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating Tricuspid Atresia from other Disorders

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Cardiac Catheterization

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Special Scenarios

Pregnancy

Case Studies

Case #1

Tricuspid atresia overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tricuspid atresia overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tricuspid atresia overview

CDC on Tricuspid atresia overview

Tricuspid atresia overview in the news

Blogs on Tricuspid atresia overview

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Tricuspid atresia overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor-In-Chief: Sara Zand, M.D.[2]Keri Shafer, M.D. [3] Priyamvada Singh, MBBS [4]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [5]

Overview

Tricuspid atresia is the third most common cyanotic congenital heart disease whether the nonoxygenated blood can not flow from right atrium to right ventricle due to nondevelopment or agenesia of the tricuspid valve. The right ventricle is small and the pulmonary artery in some cases is hypoplastic. Atrial septal defect (ASD) or patent foramen oval (PFO) is necessary for passing the blood from the right atrium to the left system and without them, the infants will not survive. The majority of infants die without palliative surgery.